Caleb DesRosiers - Jul 11, 2023 Form 4 Insider Report for DAXOR CORP (DXR)

Role
Director
Signature
/s/ Caleb DesRosiers
Stock symbol
DXR
Transactions as of
Jul 11, 2023
Transactions value $
$0
Form type
4
Date filed
7/13/2023, 04:48 PM
Previous filing
Nov 18, 2022
Next filing
Jul 17, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DXR Stock options (right to buy) Award $0 +2.5K $0.00 2.5K Jul 11, 2023 Common Stock 2.5K $9.88 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted on July 11, 2022 are contingent on the approval of the Securities & Exchange Commission ("SEC") to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan")
F2 The stock options will vest in three (3) installments - July 11, 2024 (833); July 11, 2025 (834); July 11, 2026 (666)